Fail in mean arterial pressure and fetal growth restriction in pregnancy hypertension: A meta-analysis

Lancet

Volumn 355, Issue 9198, 2000, Pages 87-92

  Von Dadelszen, P ^a   Ornstein, M P ^a   Bull, S B ^a   Logan, A G ^a   Koren, G ^b   Magee, L A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; FEMALE; FETUS; HUMAN; INTRAUTERINE GROWTH RETARDATION; MATERNAL HYPERTENSION; MEAN ARTERIAL PRESSURE; META ANALYSIS; NEWBORN; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK BENEFIT ANALYSIS; SMALL FOR DATE INFANT; BIRTH WEIGHT; DRUG EFFECT; HYPERTENSION; PREGNANCY; PREGNANCY COMPLICATION;

ANTIHYPERTENSIVE AGENTS; BIRTH WEIGHT; FEMALE; HUMANS; HYPERTENSION; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; REGRESSION ANALYSIS;

EID: 0034620112     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)08049-0     Document Type: Article

References (60)

1. Report on high blood pressure in pregnancy. Am J Obstet Gynecol. 163:1990;1691-1712.
2. Khong T.Y., de Wolf F., Robertson W.B., Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational-age infants. Br J Obstet Gynaecol. 93:1986;1049-1059.
3. Zuspan F.P., O'Shaughnessy R.W. Maternal physiology and diseases: chronic hypertension in pregnancy. Pitkin R.M., Zlatnik F.J. Yearbook of obstetrics and gynecology. 1979;11 Yearbook Medical Publishers, Chicago.
4. Magee L.A., Ornstein M.P., von Dadelszen P. Clinical review: management of mild to moderate pregnancy hypertension. BMJ. 318:1999;1332-1336.
5. Collins, R., Duley, L. Any antihypertensive therapy for pregnancy hypertension. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, eds. Pregnancy and childbirth module. In Cochrane Library review no 04426, Cochrane Collaboration, April 21. Oxford: Update Software, 1994.
6. Butters L., Kennedy S., Rubin P.C. Atenolol in essential hypertension during pregnancy. BMJ. 301:1990;587-589.
7. Redman C.W.G. Controlled trials of antihypertensive drugs in pregnancy. Am J Kidney Dis. 17:1991;149-153.
8. Tyson J.E., Kennedy K., Broyles S., Rosenfeld C.R. The small for gestational age infant; accelerated or delayed pulmonary maturation? Increased or decreased survival? Pediatrics. 95:1995;534-538.
9. Barker D.J. The Wellcome Lecture, 1994. The fetal origins of adult disease. Proc R Soc Lond B Biol Sci. 262:1995;37-43.
10. Briggs, G.G., Freeman, R.K., Yaffe, S.K., eds. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk, 4th edn. Baltimore: Williams & Wilkins, 1994.
11. Fleiss J.L. The statistical basis of meta-analysis. Stat Method Med Res. 2:1993;121-145.
12. Berlin J.A., Antman E.M. Advantages and limitations of metaanalytic regressions of clinical trials data. Online J Curr Clin Trials. 3:1994;. (document no 132).
13. Greenland S. A critical look at some popular meta-analytic methods. Am J Epidemiol. 140:1994;290-301.
14. Sibai B.M., Grossman R.A., Grossman H.G. Effects of diuretics in plasma volume in pregnancies with long-term hypertension. Am J Obstet Gynaecol. 150:1984;831-835.
15. Arias F., Zamora J. Antihypertensive treatment and pregnancy outcome in patients with mild chronic hypertension. Obstet Gynecol. 53:1978;489-494.
16. Sibai B.M., Mabie W.C., Shamsa F., Villar M.A., Anderson G.D. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol. 162:1990;960-967.
17. Weitz C., Khouzami V., Maxwell K., Johnson J.W.C. Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study. Int J Gynaecol Obstet. 25:1987;35-40.
18. Steyn D.W., Odendaal H.J. Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia. Lancet. 350:1997;1267-1271.
19. Menzies D.N. Controlled trial of chlorothiazide in treatment of early pre-eclampsia. BMJ. 1:1964;739-742.
20. Leather H.M., Baker P., Humphreys D.M., Chadd M.A. A controlled trial of hypotensive agents in hypertension in pregnancy. Lancet. ii:1968;488-490.
21. Redman C.W.G., Beilin L.J., Bonnar J., Ounsted M.K. Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet. ii:1976;753-756.
22. Rubin P.C., Butters L., Clark D.M.et al. Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. Lancet. i:1983;431-434.
23. Cruickshank D.J., Robertson A.A., Campbell D.M., MacGillivray I. Maternal obstetric outcome measured in a randomised controlled study of labetalol in the treatment of hypertension in pregnancy. Clin Exp Hypertens Pregn. 10:1991;333-344.
24. Pickles C.J., Symonds E.M., Broughton Pipkin F. The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension. Br J Obstet Gynaecol. 96:1989;38-43.
25. Sibai B.M., Gonzales A.R., Mabie W.C., Moretti M. A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term. Obstet Gynecol. 70:1987;323-327.
26. Walker J.J., Crooks A., Erwin L., Calder A.A. Labetalol in pregnancy-induced hypertension: fetal and maternal effects. Reily A., Symonds E.M. International Congress Series 591. 1982;148-160 Excerpta Medica, Amsterdam.
27. Hogstedt S., Lindberg B., Lindeberg S., Ludviksson K. Effect of metoprolol on fetal heart rate patterns during pregnancy and delivery. Clin Exp Hypertens Pregn. 3:1984;152.
28. Wichman K., Ryden G., Karlberg B.E. A placebo controlled trial of metoprolol in the treatment of hypertension in pregnancy. Scand J Lab Invest. 169:1984;90-95.
29. Plouin P.F., Breart G., Llado J.et al. A randomised comparison of early with consecutive use of antihypertensive drugs in the management of pregnancy-induced hypertension. Br J Obstet Gynaecol. 97:1990;134-141.
30. Bott-Kanner G., Hirsch M., Friedman S.et al. Antihypertensive therapy in the management of hypertension in pregnancy - a clinical double-blind study of pindolol. Clin Exp Hypertens Pregn. 11:1992;207-220.
31. Sibai B.M., Barton J.R., Akl S., Sarinoglu C., Mercer B.M. A randomized prospective comparison of nifedipine and bed rest versus bed rest alone in the management of preeclampsia remote from term. Am J Obstet Gynecol. 167:1992;879-884.
32. Wide-Swensson D.H., Ingemarsson I., Lunell N.O.et al. Calcium channel blockade (isradipine) in treatment of hypertension in pregnancy: a randomized placebo-controlled study. Am J Obstet Gynecol. 173:1995;872-878.
33. Phippard A.F., Fischer W.E., Horvath J.S.et al. Early blood pressure control improves pregnancy outcome in primigravid women with mild hypertension. Med J Aust. 154:1991;378-382.
34. Lardoux H., Blazquez G., Leperlier E., Gerard J. Essai overt, comparatif, avec tirage au sort pour le traitement de l'HTA gravidique moderée: methyldopa, acebutolol, labetalol. Arch Mal Coeur. 81:1988;137-140. (suppl HTA).
35. Plouin P.F., Breart G., Maillard F., Papiernik E., Relier J.P. Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial. Br J Obstet Gynaecol. 95:1988;868-879.
36. Lamming G.D., Broughton Pipkin F., Symonds E.M. Comparison of the alpha and beta blocking drug, labetalol, and methyldopa in the treatment of moderate and severe pregnancy-induced hypertension. Clin Exp Hypertens Pregn. 2:1980;865-895.
37. Redman CWG.A controlled trial of the treatment of hypertension in pregnancy: labetalol compared with methyldopa. International Congress Series 591 Amsterdam: Excerpta Medica 1978: 101-110.
38. El-Qarmalawi A.M., Morsy A.H., Al-Fadly A., Obeid A., Hashem M. Labetalol vs methyldopa in the treatment of pregnancy-induced hypertension. Int J Gynaecol Obstet. 49:1995;125-130.
39. Oumachigui A., Verghese M., Balachander J. A comparative evaluation of metoprolol and methyldopa in the management of pregnancy-induced hypertension. Ind Heart J. 44:1992;39-41.
40. Gallery E.D.M., Ross M.R., Gyory A.Z. Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa. BMJ. 291:1985;563-566.
41. Fidler J., Smith V., Fayers P., de Swiet M. Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy. BMJ. 286:1983;1927-1930.
42. Ellenbogen A., Jaschevatzky O., Davidson A., Anderman S., Grunstein S. Management of pregnancy-induced hypertension with pindolol: comparative study with methyldopa. Int J Gynaecol Onstet. 24:1986;3-7.
43. Livingstone I., Craswell P.W., Bevan E.B. Propranolol in pregnancy; three year prospective study. Clin Exp Hypertens Pregn. 2:1983;341-350.
44. Hjertberg R., Faxelius G., Lagercrantz H. Neonatal adaption in hypertensive pregnancy - a study of labetalol vs hydralazine treatment. J Perinat Med. 21:1993;69-75.
45. Rosenfeld J.B. Antihypertensive therapy in the management of hypertensio in pregnancy - a clinical double-blind study of pindolol. Clin Exp Hypertens Pregn. 11:1992;207-220.
46. Paran E., Holzberg G., Mazor M., Zmora E., Insler V. β-adrenergic blocking agents in the treatment of pregnancy-induced hypertension. Int J Pharmacol Ther. 33:1995;119-123.
47. Montan S., Ingemarsson I., Marsal K., Sjoberg N.O. Randomised controlled trial of atenolol and pindolol in human pregnancy: effects on fetal haemodynamics. BMJ. 304:1992;946-949.
48. Jannet D., Carbonne B., Sebban E., Milliez J. Nicardipine versus metoprolol in the treatment of hypertension during pregnancy: a randomized comparative trial. Obstet Gynecol. 84:1994;354-359.
49. Marlettini M.G., Crippa S., Morelli-Labate A.M., Contarini A., Orlandi C. Randomized comparison of calcium antagonists and beta-blockers in the treatment of pregnancy-induced hypertension. Curr Ther Res. 45:1990;684-694.
50. Montan S., Anandakumar C., Arulkumaran A., Ingemarsson I., Ratnam S.S. Randomised controlled trial of methyldopa and israpidine in preeclampsia - effects on uteroplacental and fetal hemodynamics. J Perinat Med. 24:1996;177-184.
51. Wide-Swensson D., Montan S., Arulkumaran S., Ingemarsson I., Ratnam S.S. Effect of methyldopa and isradipine in fetal heart rate pattern assessed by computerized cardiotocography in human pregnancy. Am J Obstet Gynecol. 169:1993;1581-1585.
52. Voto L.S., Zin C., Neira J., Lapidus A.M., Margulies M. Ketanserin versus α-methyldopa in the treatment of hypertension during pregnancy: a preliminary report. J Cardiovasc Pharmacol. 10:1987;101-103.
53. Horvath J.S., Phippard A., Korda A., Henderson-Smart D.J., Child A., Tiller D.J. Clonidine hydrochloride - a safe and effective antihypertensive agent in pregnancy. Obstetrics. 66:1985;634-638.
54. Rey E., LeLorier J., Burgess E., Lange I.R., Leduc L. Report of Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders of pregnancy. CMAJ. 157:1997;1245-1254.
55. Ley D., Wide-Swensson D., Lindroth M., Svenningsen N., Marsal K. Respiratory distress syndrome in infants with impaired intrauterine growth. Acta Paediatr. 86:1997;1090-1096.
56. Cooper P.A., Sandler D.L., Simchowitz I.D., Galpin J.S. Effects of suboptimal intra-uterine growth on preterm infants between 30 and 32 weeks' gestation. S Afr Med J. 87:1997;314-318.
57. Lau J., Ioannidis J.P.A., Schmid C.H. Quantitative synthesis in systemic reviews. Ann Intern Med. 127:1997;820-826.
58. Borzak S., Ridker P.M. Discordance between meta-analyses and large-scale randomized, controlled trials. Ann Intern Med. 123:1995;873-877.
59. Sibai B.H. Treatment of hypertension in pregnant women. N Engl J Med. 335:1996;257-265.
60. Redman C.W.G. Hypertension in pregnancy. de Swiet M. Medical disorders in obstetric practice, 3rd edn. 1995;182-225 Blackwell, Oxford.